![Scott Kellen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 422 371 $ al 31/07/2026
Scott Kellen currently works at DiaMedica Therapeutics, Inc., as Chief Financial Officer & Secretary from 2018.
Mr. Kellen also formerly worked at Transoma Medical, Inc., as Finance Director from 2007 to 2009, ev3, Inc., as Controller from 2005 to 2007, Kips Bay Medical, Inc., as COO, CFO, Secretary, VP & Head-Investor Relations from 2012 to 2015, Sun Biopharma, Inc., as Chief Financial Officer & Vice President, Deloitte & Touche LLP, as Senior Audit Manager from 2003 to 2005, and Panbela Therapeutics, Inc., as Chief Financial Officer, Secretary, CAO & VP from 2015 to 2018.
Mr. Kellen received his undergraduate degree from the University of South Dakota.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/06/2026 | 34.330 ( 0,06 % ) | 217 652 $ | 31/07/2026 | |
| 01/06/2026 | 32.290 ( -.--% ) | 204 719 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Director Financiero/CFO | 01/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| SUN BIOPHARMA INC | Director Financiero/CFO | 01/04/2018 |
Transoma Medical, Inc.
 Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Manufactures and distributes implantable, wireless diagnostic and monitoring systems | Director Financiero/CFO | 01/05/2009 |
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Comptroller/Controller/Auditor | 01/10/2007 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 01/04/2005 |
Sun Biopharma, Inc. /Old/
 Sun Biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Kips Bay Medical, Inc.
 Kips Bay Medical, Inc. Medical SpecialtiesHealth Technology Engages in the development, manufacturing and commercialization of proprietary external saphenous vein support technology | Health Technology |
Sun Biopharma, Inc. /Old/
Sun Biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of South Dakota
 University of South Dakota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Manufactures and distributes implantable, wireless diagnostic and monitoring systems | Health Services |
Panbela Therapeutics, Inc.
 Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
